Received Nov 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | 4 | UK175AA | OT / LL |
Act-hib expired it was given to a patient with no reported adverse event; Initial information received on 07-Nov-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 1-year-old female patient who was given HIB (PRP/T) vaccine [ACT-HIB] which was expired with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Pneumococcal vaccine conj 7v (CRM197) (Prevnar); and Diphtheria vaccine toxoid, Pertussis vaccine acellular, Tetanus vaccine toxoid (Dtap) for Immunisation. On 07-Nov-2025, the patient received a 0.5 ml dose (dose 4) of expired suspect HIB (PRP/T) Vaccine Powder and solvent for solution for injection strength: standard of lot UK175AA and expiry date: 31-Oct-2025 via intramuscular route in the left thigh for Immunization with no reported adverse event (expired product administered) (latency; on same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Prevnar; Dtap